Methylene blue benefits get sold hard in wellness circles — better cognition, more energy, anti-aging, mitochondrial enhancement, mood support. The honest version is more mixed: it has real established medical uses, some interesting exploratory research on cognition, and a number of claims that don’t hold up under scrutiny.
Here’s an evidence-graded list, with realistic context for each claimed benefit.
For the broader picture, see methylene blue and is methylene blue safe.
Lose weight
Gain muscles
Eat healthy
Explore new cuisines
Lisa C.
Available on the App StoreTier 1: Established medical uses (strong evidence)
These are FDA-approved or standard medical applications.
1. Treats methemoglobinemia
The original medical use. Methemoglobin is a non-functional form of hemoglobin that can’t carry oxygen. IV methylene blue (1–2 mg/kg) reduces methemoglobin back to functional hemoglobin within minutes. Lifesaving in acute cases.
2. Surgical tissue identification
Used as a dye in parathyroid surgery, lymph node mapping, and other procedures. Standard and effective.
3. Septic shock (research/off-label)
Used for refractory vasoplegia (severe shock not responding to standard treatment). Reasonable evidence for short-term blood pressure support.
4. Cyanide poisoning antidote (historical)
Older treatment, less common now.
These are not what wellness marketers are selling. But they confirm methylene blue is a legitimate pharmaceutical.
Tier 2: Cognitive effects (interesting, limited)
Where the wellness market gets most of its claims:
5. Cognitive function — limited but interesting evidence
Animal studies have consistently shown methylene blue improves memory and cognition in various models. A 2021 rat study in hepatic encephalopathy showed methylene blue improved cognitive performance via effects on cytochrome c-oxidase activity in the brain.1
Human evidence is sparser. Some imaging studies have shown low-dose methylene blue produces measurable changes in brain activation patterns and modest improvements in short-term memory in healthy adults. Effects appear strongest at low doses (0.5–4 mg/kg).
The mechanism: methylene blue acts as an electron carrier in mitochondria, potentially supporting brain energy production.
Honest caveats:
- The doses studied are very low (often 0.5–1 mg/kg, much higher than typical wellness drop doses)
- Effects in healthy adults are small to moderate
- Effects in clinical populations (Alzheimer’s, dementia) have been disappointing in larger trials
- The methylene blue derivative LMTM was tested in Alzheimer’s; results were equivocal
Tier 3: Mitochondrial and “energy” claims (mechanistic, weak human data)
6. Mitochondrial function
Mechanistically, methylene blue can shuttle electrons in the mitochondrial respiratory chain, potentially compensating for inefficient electron transport. This is real biochemistry.
In practice:
- Animal studies show effects on mitochondrial parameters
- Human studies of subjective energy, mitochondrial markers, or functional outcomes are limited
- Most “I feel more energized” reports are anecdotal
7. Antimicrobial properties
Documented anti-bacterial, anti-viral, and anti-fungal activity in lab studies. Used historically for malaria. Some interest in repurposing for various infections.
For routine wellness use, this isn’t a meaningful benefit — you’re not treating an infection.
Tier 4: Mostly hype
Several frequently claimed benefits that don’t have strong evidence at the doses used in wellness:
“Reverses aging”
Animal cellular health data is interesting. Human longevity evidence doesn’t exist. The “anti-aging” claim is largely marketing.
Suggested read: Methylene Blue Side Effects: Risks and Drug Interactions
“Cures Alzheimer’s”
The LMTM derivative was tested in major late-stage Alzheimer’s trials. Results were equivocal at best. Pharmaceutical-grade methylene blue isn’t an approved or recommended Alzheimer’s treatment.
“Eliminates brain fog”
Subjective reports exist. Controlled human evidence is sparse. The MAOI activity may produce some mood-elevating effects that get interpreted as “clearer thinking.”
“Treats depression”
Some interest exists due to MAOI activity, but methylene blue isn’t a recommended depression treatment. The drug interactions with established antidepressants make it dangerous in this context.
“Detoxifies the body”
Vague claim, not biologically meaningful.
What the wellness dose actually does
Most wellness products contain 1–10 mg of methylene blue per dose. For perspective:
- The methemoglobinemia dose is 1–2 mg/kg = 70–140 mg for a 70 kg adult
- The cognitive research dose is 0.5–4 mg/kg = 35–280 mg
- The wellness dose is 1–10 mg total = 10–100 times less than studied doses
At wellness doses, methylene blue likely has limited measurable effect on most outcomes. The placebo factor is probably substantial.
This isn’t necessarily bad — low doses limit side effects too — but it does mean people taking 1–5 mg sublingual drops likely aren’t getting the same effects studied in trials.
Specific population considerations
Healthy adults
Most wellness users. Modest effects likely; safety risks low at very low doses with quality material.
Active illness
Not a substitute for established treatments. Don’t use as primary treatment for infections or other conditions.
People on antidepressants
Avoid completely. The MAOI activity creates serious serotonin syndrome risk.2 This isn’t theoretical — it’s well-documented.
Suggested read: NAD Benefits: What Research Actually Shows
G6PD deficiency
Avoid completely. Methylene blue can cause severe hemolysis (red blood cell destruction).
Pregnancy/breastfeeding
Avoid; safety data is insufficient.
Comparison to other “cognitive enhancers”
Methylene blue in context with other commonly used compounds:
| Compound | Cognitive evidence | Safety profile |
|---|---|---|
| Caffeine | Strong, well-studied | Excellent at moderate doses |
| L-theanine | Modest, well-studied | Excellent |
| Creatine | Emerging cognitive evidence | Excellent |
| Omega-3s | Strong for some populations | Excellent |
| Magnesium L-threonate | Limited but interesting | Good |
| Methylene blue (low dose) | Limited, mostly animal | Drug interactions concerning |
| Noopept, racetams | Mixed | Less studied |
Most adults seeking cognitive support get better evidence and safer profiles from established options before getting to methylene blue.
Common questions
Will methylene blue make me smarter? Probably not in any meaningful, sustained way at wellness doses. Some users report subjective focus improvements; controlled evidence is limited.
Is it FDA-approved for cognition? No. FDA approval is specifically for methemoglobinemia.
How long until I notice effects? Acute subjective effects appear within an hour at higher doses. At wellness doses, effects are usually subtle if present at all.
Can I take it long-term? Long-term safety data at wellness doses is limited. Long-term high-dose use has cardiovascular and other concerns.
Should I take it for depression? No. Use established antidepressants under medical guidance. Methylene blue’s MAOI activity creates dangerous interactions with most depression medications.
Will it interfere with my workouts? Probably not at low doses. High doses can affect exercise tolerance.
When methylene blue might genuinely help
Specific scenarios where the evidence supports use:
- Methemoglobinemia (medical emergency, hospital setting)
- Surgical mapping (clinical use)
- Specific clinical research protocols under medical supervision
For everything else, the evidence-to-marketing gap is wide, and the drug interactions matter.
Bottom line
Methylene blue has legitimate medical uses backed by strong evidence, particularly for methemoglobinemia. Its cognitive benefits in healthy adults are modest at best at the doses studied — and the wellness-market doses are much lower than research doses. Mitochondrial and “anti-aging” claims are mechanistically interesting but not supported by robust human outcomes. The MAOI drug interactions are real and dangerous, particularly with antidepressants. If you want cognitive support, established options (magnesium, omega-3s, exercise, sleep, creatine) have stronger evidence and cleaner safety profiles. Methylene blue earns its place in pharmacology, not in routine wellness use.
Méndez M, Fidalgo C, Arias JL, Arias N. Methylene blue and photobiomodulation recover cognitive impairment in hepatic encephalopathy through different effects on cytochrome c-oxidase. Behav Brain Res. 2021;403:113164. PubMed ↩︎
Gillman PK. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. J Psychopharmacol. 2011;25(3):429-36. PubMed ↩︎
Sarah M.
Linda P.
Maya T.
Marcus J.
Emma R.
Amanda K.
Chris B.
David L.
James W.
Jennifer S.
Kevin H.
Lisa C.
App Store ★★★★★
